You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

untreated childhood acute myeloid leukemia and other myeloid malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • (no location specified)
May 29, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 1, 2023

Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6) Trial in

Completed
Has Results
  • Childhood Acute Basophilic Leukemia
  • +14 more
  • Phoenix, Arizona
  • +96 more
Jan 20, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

Not yet recruiting
  • Myeloid Malignancies
  • +3 more
  • (no location specified)
Mar 22, 2023

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

Not yet recruiting
  • Myeloid Malignancy
  • +4 more
  • Telehealth Serious Illness Care Program
  • Education Control
  • Rochester, New York
    University of Rochester
May 24, 2023

DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • +8 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Childrens Oncology Group
Jul 12, 2022

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

    Recruiting
    • Acute Myelogenous Leukemia (AML) Due to Therapy
    • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
    • Orange, California
    • +2 more
    Nov 30, 2022

    Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Duarte, California
    • +9 more
    Jan 3, 2023

    Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Fludarabine, busulfan and melphalan
    • Fludarabine and Busulfan
    • Fuzhou, Fujian, China
    • +8 more
    Aug 14, 2023

    Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • +3 more
    • Venetoclax plus RIC
    • Shanghai, Shanghai, China
      Shanghai General Hospital
    Oct 12, 2022

    Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)

    Completed
    Has Results
    • Untreated Adult Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 28, 2022

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

    Not yet recruiting
    • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
    • +3 more
    • (no location specified)
    Nov 14, 2022

    Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Azacitidine and Venetoclax
    • Aurora, Colorado
      University of Colorado Denver
    Aug 1, 2022

    Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 10, 2022

    Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

    Not yet recruiting
    • Leukemia
    • +12 more
    • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
    • (no location specified)
    Mar 20, 2023

    Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myeloid Neoplasm
    • Biospecimen Collection
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 5, 2023

    Relapsed and/or Refractory Acute Myeloid Leukemia, High Risk Hematologic Malignancies Trial in Langfang (anti-CD33 CAR T cells)

    Not yet recruiting
    • Relapsed and/or Refractory Acute Myeloid Leukemia
    • High Risk Hematologic Malignancies
    • anti-CD33 CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

    Recruiting
    • Acute Myeloid Leukemia
    • Lanzhou, Gansu, China
      Long Zhao
    Apr 24, 2022